Delivery Order SPE2DX22D0010-SPE2D824FMU82
Award Date 5/24/24
Potential Completion Date 5/28/24
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,162.63 firm fixed price delivery order is for the supply of 10mg dextroamphetamine extended-release capsules. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of dextroamphetamine extended-release capsules. The award, valued at $1,830.77, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor for this...
- This federal contract award, valued at $1,532.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,164,844 capsules of 10 mg dextroamphetamine extended-release medication. The contract has a period of performance through May 7, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,809.93 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,464,709 units of 15 mg dextroamphetamine extended-release capsules. The contract has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of dextroamphetamine extended-release 10 mg capsules. The contract has a ceiling value of $1,329.34 and a completion date of June 26, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $2,045.01 firm-fixed-price delivery order is for the supply of 4,566,066,914 units of Dextroamphetamine Extended-Release 15mg Capsules in 100-count packages. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the supply of 10 mg Dextroamphetamine-Amphetamine capsules. The award, valued at $3,465.94, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency under the Department of Defense. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,532.64 and is for the delivery of 4,568,107,645 units of the prescription medication Dextroamphetamine ER 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,148,126 units of dextroamphetamine extended-release 15 mg capsules. The $1,508.38 Firm Fixed Price contract runs from October 2022 to October 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,566,067,233 units of dextroamphetamine extended-release 10 mg capsules in 90-count bottles, with a ceiling value of $5,235.29. The contract has an ultimate completion date of October 10, 2024 and does not utilize any set-aside designations....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FMU82Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,316.40, is for the delivery of dextroamphetamine extended-release capsules (10mg). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 8/23/24, 4:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/24/24 |